Лучшие подкасты про JNNP (2025)

1
Distinguishing autoimmune nodopathies from CIDP, with Dr. Ruth Huizinga and Dr. Maarten Titulaer 38:57

7M ago38:57

38:57

Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) can be difficult to distinguish from autoimmune nodopathy. In this podcast, Dr. Saima Chaudhry (1) is joined from the Netherlands by Dr. Ruth Huizinga (2) and Dr. Maarten Titulaer (3), to discuss their article, "Clinical relevance of distinguishing autoimmune nodopathies from CIDP: lo…

1
Nutritional peripheral neuropathies, with Dr. Alexander Rossor 39:42

10M ago39:42

39:42

The cause of a nutritional neuropathy may not always be obvious when first examining a patient. Restrictive diets with roots in religious practices or personal preferences will be less familiar to neurologists than issues involving bariatric surgery or diseases of malabsorption, and can present as being not overtly malnourished. A recent review in …

1
Distinguishing primary from functional tics 40:02

12M ago40:02

40:02

How often do movement disorder specialists agree when classifying tics? A recent study published in JNNP explores this question with a two-stage approach, seeking a diagnosis from experts first based on video evidence alone and then following the provision of additional clinical data. The study's last author, Dr. Christos Ganos (1), joins host Dr. …

1
Nitrous Oxide Abuse 27:45

1+ y ago27:45

27:45

With the UK government announcing plans to make recreational use of nitrous oxide illegal, JNNP podcast host Dr. Saima Chaudhry (1) is joined by London-based neurologist Dr. Alastair Noyce (2)(3) to examine the findings of his group's recently published research paper, "Nitrous oxide-induced myeloneuropathy: a case series". Read the paper here: htt…

1
Brain Fog Demystified 30:15

1+ y ago30:15

30:15

Social media platforms and clinical patient encounters are abundant in references to brain fog, but how much is it really understood? In this episode, JNNP's podcast host, Dr. Saima Chaudhry (1), speaks with Dr. Laura McWhirter (2) about her recently published article, "What is Brain Fog?"and how further understanding of this can help to better tre…

1
A roadmap to ALS prevention: strategies and priorities 38:29

1+ y ago38:29

38:29

In this episode, JNNP's new podcast host Dr. Saima Chaudhry (1) speaks with Dr. Michael Benatar (2) about his recently published article, "A roadmap to ALS prevention: strategies and priorities". This explores a new approach to Amyotrophic lateral sclerosis, with an emphasis on earlier treatment before significant damage has occurred. This is impor…

1
MOGAD: Definition, diagnosis and treatment 21:17

1+ y ago21:17

21:17

In this episode, JNNP's new podcast host Dr. Saima Chaudhry (1) speaks with Dr. Matteo Gastaldi (2) about Myelin oligodendrocyte glycoprotein antibody-associated disease, or MOGAD for short. A multi-centre retrospective study, "Prognostic relevance of quantitative and longitudinal MOG antibody testing in patients with MOGAD", was recently published…

1
CGRP in migraine: current therapeutics, future implications and potential off-target effects 10:01

3y ago10:01

10:01

In this podcast, JNNP's Podcast Editor, Colin Mahoney, interviews Dr Jason Ray (Neurology, Alfred Health, and Department of Neuroscience, Monash University, Melbourne). Dr Ray discusses the role of calcitonin gene related peptide in migraine and the growing body of evidence for the role of therapies directed against this protein in migraine and bey…

1
Alemtuzumab’s impact on functional and structural integrity of the visual system in MS 20:02

3y ago20:02

20:02

Prof Michael Barnett, Director Sydney Neuroimaging Analysis Centre and Professor of Neurology, University of Sydney, joins JNNP's Podcast Editor, Colin Mahoney, to discuss how the use of Alemtuzumab may have longer-term impacts on improving one of the most commonly involved neurological pathways, the visual system, in multiple sclerosis (MS). Prof …

1
Guidelines for the management of functional speech and communication disorders 23:09

3+ y ago23:09

23:09

A/Prof Jan Baker, Speech Pathologist, Flinders University and UTS. Dr Laura McWhirter, University of Edinburgh joins editor Colin Mahoney to discuss the first comprehensive guidelines developed to assist speech and language professionals in the management of functional communication, voice, swallow and cough disorders. As part of a global team they…

1
The impact of traumatic brain injury on neurocognitive outcomes in children 9:54

3+ y ago9:54

9:54

Mark Goh and Shu-Ling Chong, Duke-NUS Medical School and KK Women's and Children's Hospital, Singapore joins editor Colin Mahoney to discuss their systematic review and meta-analysis spanning 6000 articles dealing with neurocognitive outcomes following traumatic brain injury (TBI) in children. They highlight how dose of TBI impacts executive functi…

1
Cerebral Microbleeds: from depiction to interpretation 10:23

3+ y ago10:23

10:23

Cerebral Microbleeds are increasingly recognised due to increased availability of neuroimaging and are known to be associated with increased risk of stroke, in particular intracerebral haemorrhage. In this podcast Dr Laurent Puy joins editor Colin Mahoney to discuss their histopathology, epidemiology and impact on clinical decision making in a stat…

1
Motor functional neurological disease, a decade of progress 9:52

3+ y ago9:52

9:52

Over the last ten years, huge progress has been made in the common but often poorly understood condition of motor Functional Neurological Disorder (mFND). In this podcast, Dr W. Curt La France, Jr., Professor of Neurology and Psychiatry, Brown University, USA, joins editor Colin Mahoney to discuss diagnosis, insights on disease mechanisms, and emer…

1
COVID - 19 Vaccination and risk of large vessel arterial stroke 13:15

3+ y ago13:15

13:15

The Oxford Astra Zeneca vaccine has been associated with a rare complication of cerebral venous sinus thrombosis. Dr Colin Mahoney, JNNP Podcast Editor, interviews Prof David Werring, Professor of Clinical Neurology, UCL Queen Square Institute of Neurology, UK, about the new evidence which supports an association between vaccination and more common…

1
Drug repurposing for progressive multiple sclerosis 8:48

4y ago8:48

8:48

Prof Alaisdair Coles and Dr Nick Cunniffe, The University of Cambridge joins editor Colin Mahoney to discuss: The work carried out by a team of researchers alongside the MS Society in the United Kingdom. The authors discuss the process of identifying therapies to repurpose in future MS trials and why they think this drugs may work. https://jnnp.bmj…

1
Isaacs syndrome the crossroads of Neurology, Psychiatry and Immunology 11:56

4y ago11:56

11:56

Rick Thurbon, patient editorial board member. Prof Matthew Kiernan and A/Prof Susanna Park from The University of Sydney joins editor Colin Mahoney to discuss: In 1960 a landmark paper was published by Hyam Isaac on a syndrome of continuous muscle activity. The spectrum of Isaac's Syndrome has broadly widened since then and we reflect on this with …

1
Apathy, cerebral small vessel disease and future dementia risk 8:07

4+ y ago8:07

8:07

Jonathan Tay joins our podcast editor Colin Mahoney to discuss the findings from two large cohort studies of cerebral small vessel disease, highlighting the fact that apathy can predict future dementia risk in these patients. https://jnnp.bmj.com/content/91/9/953BMJ Group

1
Performance validity tests - Their role in neuropsychology assessments 12:29

4+ y ago12:29

12:29

Dr Laura Mc Whirter joins our podcast editor Colin Mahoney to discuss her recent systematic review of performance validity tests used across a range of neurological and psychiatric disorders. Are these tests useful and which conditions are the most likely to be helpful in. Join us to find out. https://jnnp.bmj.com/content/91/9/945…

1
Parkinson’s disease: etiopathogenesis and treatment 24:02

4+ y ago24:02

24:02

Prof Joseph Jankovic, Distinguished Chair in Movement Disorders, Baylor College of Medicine joins Podcast editor Colin Mahoney. Prof Jankovic provides a historical look back on the key developments in our understanding of the causes of Parkinson's disease and key treatments. https://jnnp.bmj.com/content/91/8/795…

1
Outcome measurement in functional neurological disorder a systematic review and recommendations 12:41

4+ y ago12:41

12:41

Dr Timothy Nicholson joins Podcast editor Colin Mahoney to discuss their recent systematic review of outcome measures used across the spectrum of functional neurological disorders. As well as identifying key domains for assessment he also discusses the challenges and future directions in developing more rigorous validated outcome measures for these…

1
Clinical profiles of patients with dementia and chronic traumatic encephalopathy 16:23

4+ y ago16:23

16:23

Dr Christian Lobue, lead author joins Podcast Editor Colin Mahoney to discuss his original research which examines the clinical, neuropsychological and neuropsychiatric features of those with confirmed chronic traumatic encephalopathy (CTE) at autopsy. He compares the features with patients with CTE and those with Alzheimer's disease. https://jnnp.…

1
Visual hallucinations in neurological and ophthalmological disease 22:08

4+ y ago22:08

22:08

Prof John O'Brien (University of Cambridge) and Dr Dominic Ffytche (Kings College London) join Dr Colin Mahoney (Podcast Editor) Visual hallucinations have complex origins and can have significant impact on patients. The recent UK based SHAPED consortium has aimed to design a common framework for assessment, management and research in this area. Jo…

1
Primary Lateral Sclerosis: new consensus criteria 14:04

4+ y ago14:04

14:04

Prof Martin Turner, University of Oxford, joins Dr Colin Mahoney to discuss the newest consensus clinical criteria to aid in the diagnosis of Primary Lateral Sclerosis. This will enable neurologists to make the diagnosis sooner and will be important in the design of future treatment trials. https://jnnp.bmj.com/content/91/4/373…

1
Neurology in the time of COVID - 19 15:18

5y ago15:18

15:18

Dr Hadi Manji joins Colin Mahoney to discuss the recent paper by Liu and colleagues as well as providing a commentary on how COVID-19 may impact the nervous system and steps to mitigate this. He also discusses the impact of COVID-19 in delivering care at the National Hospital for Neurology and Neurosurgery, located in one of the new epicentres for …

1
Lithium: a slow burner 20:49

5y ago20:49

20:49

Prof Andrew Lees, Professor of Neurology National Hospital for Neurology and Neurosurgery. Colin Mahoney JNNP Podcast EditorAs part of our 2020 Vision centenary Prof Andrew Lees reviews how Lithium (eventually) became established in the treatment of psychiatric illness, reviewing the 1954 paper by Schou and colleagues. https://jnnp.bmj.com/content/…

Подкасты, которые стоит послушать

Подкасты на тему JNNP

Подкасты, которые стоит послушать

1
JNNP Podcast

BMJ Group

1
Distinguishing autoimmune nodopathies from CIDP, with Dr. Ruth Huizinga and Dr. Maarten Titulaer 38:57

1
Nutritional peripheral neuropathies, with Dr. Alexander Rossor 39:42

1
Distinguishing primary from functional tics 40:02

1
Nitrous Oxide Abuse 27:45

1
Brain Fog Demystified 30:15

1
A roadmap to ALS prevention: strategies and priorities 38:29

1
MOGAD: Definition, diagnosis and treatment 21:17

1
CGRP in migraine: current therapeutics, future implications and potential off-target effects 10:01

1
Alemtuzumab’s impact on functional and structural integrity of the visual system in MS 20:02

1
Guidelines for the management of functional speech and communication disorders 23:09

1
The impact of traumatic brain injury on neurocognitive outcomes in children 9:54

1
Cerebral Microbleeds: from depiction to interpretation 10:23

1
Motor functional neurological disease, a decade of progress 9:52

1
COVID - 19 Vaccination and risk of large vessel arterial stroke 13:15

1
Drug repurposing for progressive multiple sclerosis 8:48

1
Isaacs syndrome the crossroads of Neurology, Psychiatry and Immunology 11:56

1
Apathy, cerebral small vessel disease and future dementia risk 8:07

1
Performance validity tests - Their role in neuropsychology assessments 12:29

1
Parkinson’s disease: etiopathogenesis and treatment 24:02

1
Outcome measurement in functional neurological disorder a systematic review and recommendations 12:41

1
Clinical profiles of patients with dementia and chronic traumatic encephalopathy 16:23

1
Visual hallucinations in neurological and ophthalmological disease 22:08

1
Primary Lateral Sclerosis: new consensus criteria 14:04

1
Neurology in the time of COVID - 19 15:18

1
Lithium: a slow burner 20:49

Краткое руководство